Prolific Machines
Emeryville, US · Founded 2020 · 5 known investors
Prolific Machines develops light-controlled cell line and bioprocessing solutions for biotherapeutic manufacturing, enabling precise control over protein expression to improve yields and quality for monoclonal antibodies, bispecifics, and other complex biologics. The company serves biotechs, pharmaceutical companies, and CDMOs through preclinical development services and platform licensing options.
Founders & leadership
MH
Maximilian Hörner
SM
Shahram Misaghi
AM
Amritha Menon
KM
Kiana Mohajeri
AT
Alex Toda
IR
Ian Ronningen
JH
John Haliburton
PC
Pete Czerpak
AG
Arvind GuptaDirector
CG
Campbell GrieveDirector
MH
Max HuismanExecutive Officer, Director
DK
Deniz KentExecutive Officer, Director
Investors · 5
Reported raises · per SEC filings
Form D private placements▶$54.6MraisedMay 2024 · 36 investors · Other TechnologyRule 506(b)
▶$54.6MraisedMay 2024 · 36 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Arvind GuptaDirector
- Campbell GrieveDirector
- Max HuismanExecutive Officer, Director
- Deniz KentExecutive Officer, Director
- Cooper RinzlerDirector
- Offering amount
- $57.6M
- Amount sold
- $54.6M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.